杏吧原创

Cannabis anti-convulsant shakes up epilepsy treatment

A non-psychoactive cannabis chemical controls seizures in animals with fewer side effects than currently prescribed anti-convulsants
Weeding out a solution
Weeding out a solution
(Image: WestEnd61/Rex Features)

The versatile cannabis plant may have a new use: it could be used to control epileptic seizures with fewer side effects than currently prescribed anti-convulsants.

at the University of Reading, UK, and colleagues worked with in Wiltshire, UK, to investigate the anti-convulsant properties of cannabidivarin (CBDV), a little-studied chemical found in cannabis and some other plants.

There is 鈥渂ig, historical, anecdotal evidence鈥 that cannabinoids can be used to control human seizures, says Whalley, but the 鈥渟ide-effect baggage鈥 means there have been relatively few studies of its pharmaceutical effect on this condition.

The team investigated the effectiveness of CBDV 鈥 one of around 100 non-psychoactive cannabinoids found in cannabis 鈥 as an anti-convulsant. They induced seizures in live rats and mice that had been given the drug. These animals experienced less severe seizures and lower mortality compared with animals given a placebo. The drug also had fewer side effects and was better tolerated than three of the most widely prescribed anticonvulsants.

Epileptic seizures affect about one per cent of the population. Left uncontrolled, they can lead to depression, cognitive decline and death. If you control the seizures, says Whalley, 鈥渢he chances of death drop away completely鈥. The decision about whether to test the drug in humans will be made next year.

鈥淭his is a very positive result,鈥 says , an epilepsy specialist at University College London, UK, who was not involved in the study. 鈥淲e need new drugs,鈥 he says. 鈥淔or 20-30 per cent of people with epilepsy, nothing seems to work.鈥

But he urges caution. 鈥淭he animals in the study are made epileptic,鈥 he says, which is not how epilepsy is acquired in humans. He adds that what you see in animal models doesn鈥檛 always translate directly into humans.

鈥淢ost compounds showing promise in preclinical studies never reach market,鈥 warns of the at King鈥檚 College London. 鈥淏ut I agree that these results justify progressing further down the drug development pipeline.鈥

Journal reference: , DOI: 10.1111/j.1476-5381.2012.02207.x

Topics: Epilepsy